SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY
Clinical trial NCT06590012 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06590012
- Sponsor
- Institute for Atherosclerosis Research, Russia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-29
- Primary completion
- 2027-07-15
- Enrollment
- 1228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.